Cost-Effectiveness of Combination Disease-Modifying Antirheumatic Drugs Versus Tumor Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: A Pragmatic, Randomized, Multicenter Trial
Research output: Contribution to journal › Article › peer-review
6Citations
(Scopus)
307Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Cost-Effectiveness of Combination Disease-Modifying Antirheumatic Drugs Versus Tumor Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: A Pragmatic, Randomized, Multicenter Trial'. Together they form a unique fingerprint.